Certara Completes Acquisition of Chemaxon
Provided By GlobeNewswire
Last update: Oct 2, 2024
RADNOR, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has completed the acquisition of Chemaxon.
Read more at globenewswire.com
